Skip to main content
OpenTrials
Completed

NCT Number: NCT02276638

Comparative Study of Specular Microscopes for Measurements of Cell Density, Coefficient of Variation and Hexagonality

The primary objective of this clinical study is to collect clinical data to support an FDA 510(k) submission for the Nidek CEM-530 Center point method and Corner point method. The secondary objective is to evaluate any adverse events found during the clinical study.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Andover Eye Associates

Andover, Massachusetts, 01810, United States

About this study

The primary objective of this clinical study is to collect clinical data to support an FDA 510(k) submission for the Nidek CEM-530 Center point method and Corner point method.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Non-Pathologic: Male or female subjects from 18 to 80 years old who have full legal capacity to volunteer on the date the informed consent is signed. Subjects who can follow the instructions by the clinical staff at the clinical site,and can attend examinations on the scheduled examination date. Subjects who agree to participate in the study.
  • Pathologic: Male and female subjects from 29 to 80 years old who have full legal capacity to volunteer on the date the informed consent is signed. Subjects who can follow the instructions by the clinical staff at the clinical site, and can attend examinations on the scheduled examination date. Subjects who agree to participate in the study. At least one eye with any of the following conditions:
  • History of post-op surgical trauma including bullous keratopathy
  • History of corneal transplant
  • Physical injury or trauma to the cornea
  • Long term Fuch's dystrophy, Guttata or other corneal endothelial dystrophies
  • Keratoconus
  • Long term PMMA contact lens use (greater than 3 years)

Exclusion criteria

  • Non-Pathologic: Male and female subjects from 29 to 80 years old who have full legal capacity to volunteer on the date the informed consent is signed. Subjects who can follow the instructions by the clinical staff at the clinical site, and can attend examinations on the scheduled examination date. Subjects who agree to participate in the study. At least one eye with any of the following conditions:
  • History of post-op surgical trauma including bullous keratopathy
  • History of corneal transplant
  • Physical injury or trauma to the cornea
  • Long term Fuch's dystrophy, Guttata or other corneal endothelial dystrophies
  • Keratoconus
  • Long term PMMA contact lens use (greater than 3 years)
  • Pathologic: History of cataract, refractive or ocular surgical procedures that render the cornea opaque or otherwise impact its ability to be imaged using the investigational device. Fixation problems which may prevent obtaining at least poor quality (refer to Figure 1) CEM-530 and KONAN CELLCHEK PLUS images in either eye.

Treatment and study plan

Specular Microscope Nidek CEM-530

Device

Nidek CEM-530

Specular Microscope Konan CELLCHEK XL

Device

Konan CELLCHEK XL

Primary outcomes

  1. Center Method Corneal Endothelial Cell Density

    Time frame: single time point - 1 day

  2. Center Method Coefficient of Variation of Endothelial Cell Area

    Time frame: single time point - 1 day

    Coefficient of variation(CV) is that Standard deviation (SD) divided by the average area of endothelial cell analyzed

  3. Percentage Hexagonality

    Time frame: single time point - 1 day

    Percentage hexagonality(%HEX) is that Proportion of hexagonal cells found in the analyzed endothelium

Sponsors and collaborators

Lead sponsor

Nidek Co. LTD.

Industry

Registry information

Official study title

Comparative Study of the Specular Microscopes for Center Point Method and Corner Point Method for the Measurements of Endothelial Cell Density Measurements, Coefficient of Variation of Endothelial Cell Area and % Hexagonality.

Important dates

Study start
2014
Primary completion
2014
Study completion
2014
First posted
Oct 28, 2014
Registry last updated
Mar 20, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.